Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
777 JPY | -0.13% | +0.91% | +7.77% |
Summary
- On the basis of various fundamental qualitative criteria, the company appears to be particularly poorly ranked from a medium and long-term investment perspective.
Strengths
- The earnings growth currently anticipated by analysts for the coming years is particularly strong.
- The company appears to be poorly valued given its net asset value.
- For the past year, analysts covering the stock have been revising their EPS expectations upwards in a significant manner.
Weaknesses
- The company does not generate enough profits, which is an alarming weak point.
- For the last twelve months, the trend in sales revisions has been clearly going down, which emphasizes downgraded expectations from the analysts.
Ratings chart - Surperformance
Sector: Diversified Chemicals
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+7.77% | 70.74M | - | ||
+1.22% | 76.93B | B | ||
-0.28% | 46.86B | A- | ||
+1.07% | 32.74B | C | ||
+10.05% | 18.58B | B | ||
-9.81% | 11.54B | B | ||
+6.79% | 11.14B | A- | ||
-6.33% | 9.8B | - | ||
+5.97% | 9.72B | A- | ||
+7.57% | 9.3B | C- |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- 4113 Stock
- Ratings Taoka Chemical Company, Limited